Olix Pharmaceutical said it has signed a licensing and cooperative agreement with China’s Jiangsu Hansoh Pharmaceuticals Group to research and develop siRNA (small interfering ribonucleic acid) treatments.Under the accord, the two companies plan to discover therapeutic substances for cardiovascular
CureVac said it has decided to stop developing its first-generation mRNA Covid-19 vaccine candidate, CVnCoV, due to disappointing efficacy in phase 3 clinical trials and focus on a more promising second-generation vaccine with GSK.The company expected to get approval for CVnCoV in the second quarter
The Ministry of Food and Drug Safety ordered Hana Pharm to temporarily suspend its narcotics products such as anesthetics and pain relievers.Expecting the administrative punishment will take a significant toll on its sales, the company said it would take legal actions against the MFDS. In a public f
Novo Nordisk has started a clinical trial of semaglutide, a second-generation treatment for obesity after Saxenda (liraglutide), tailored for the Korean population. Saxenda is the leading obesity treatment in Korea in terms of sales.On Sept. 30, the Ministry of Food and Drug Safety approved a phase
Cellid, a developer of virus vector Covid-19 vaccine candidate, AdCLD-CoV19-1, said it has joined the COVAX Marketplace that allocates raw materials for vaccines.The innovative market coordinated by COVAX provides suppliers with a platform to allocate or reallocate unused materials for vaccines, mob
Pharmaceutical companies are actively working with drug delivery systems (DDS) companies to develop long-acting injections.Long-acting injections are drawing much attention because they are regarded as a new “growth engine” that can overcome the shortcomings of existing treatments.The development of
LegoChem Bioscience said it has entered into a research collaboration and license option agreement to develop an antibody-drug conjugate (ADC) treatment with a Chinese biopharmaceutical firm.However, the company did not name which Chinese company, citing a contractual term.Under the accord, the two
A study conducted by MD Anderson Cancer Center, U.S., has confirmed that poziotinib can further improve the kirsten rat sarcoma virus (KRAS) inhibitory activity when administered combined with an agent inhibiting KRAS."Spectrum, a partner of Hanmi, announced that the results of the poziotinib combin
Domestic pharmaceutical companies are speeding up efforts to develop chimeric antigen receptor T (CAR-T) cell therapy after the government approved the first gene editing CAR-T treatment, Kymriah, this year, industry watchers said Thursday.Drugmakers are competing to develop the patient-tailored tre
Encouraged by investors' growing interests in the biopharmaceutical industry amid the prolonged Covid-19 pandemic, local drugmakers are going all out to secure financial resources through massive bond issuance, market watchers said Thursday.Their moves aim to invest in new businesses and strengthen
Korean consumers are increasingly purchasing fever reducers they prefer, as the nation’s Covid-19 vaccination rate is picking up.According to the Korea Disease Control and Prevention Agency, over 64.5 percent of the Korean population aged 18 or more have completed receiving the full doses of Covid-1
Biogen Korea said it would begin global phase 3 ASCEND trials of high-dose nusinersen, marketed as Spinraza, in treating patients with late-onset spinal muscular atrophy (SMA) who received Roche’s risdiplam in the past.It will conduct the second part of the ASCEND study for 2.5 years with 135 SMA pa
Takeda Korea plans to provide a new treatment option for breast cancer (BRCA) susceptibility gene-mutated ovarian cancer patients after recently receiving expanded reimbursement for Zejula.Last Friday, Zejula got expanded health insurance coverage as maintenance therapy for BRCA susceptibility gene-
Dong-A ST said that it would exclusively sell and distribute Sanofi's osteoporosis treatment Actonel (ingredient name: risedronate) 35mg, EC 35mg, and 150mg to hospitals and clinics in Korea.According to the company, Actonel is a bisphosphonate-type bone resorption inhibitor.After the body absorbs t
Pharmaceutical companies are speeding up efforts to develop a lymphocyte-activation gene 3 (LAG-3) inhibitor, a new targeted therapy.Amid the intense race to develop a LAG-3 inhibitor first, industry officials are paying attention to whether it can be a new option for patients who are resistant to e
AstraZeneca Korea said Thursday that Lynparza has become the first poly ADP-ribose polymerase (PARP) inhibitor treatment to win the Ministry of Food and Drug Safety approval to treat pancreatic and prostate cancer.The regulatory nod made Lynparza a maintenance therapy for adult patients with germlin
Psoriasis treatment has significantly improved since the mid-2000s with the arrival of biologic drugs.Therapies, including TNF-α inhibitors and interleukin inhibitors, have advanced enough to target not only PASI 75 but PASI 90 and PASI 100 in psoriasis treatment.As physicians can prescribe biologic
AbbVie’s selective and irreversible JAK inhibitor Rinvoq (upadacitinib) expanded indications for psoriatic arthritis, ankylosing spondylitis, and atopic dermatitis, in addition to the existing rheumatoid arthritis.On Tuesday, the Ministry of Food and Drug Safety authorized Rinvoq to treat psoriatic
Humedix has partnered up with a U.S. immuno-oncology developer Kineta to strengthen its CMO business and secure funding for future growth.The company said Tuesday that it has recently decided to sign a strategic investment deal with Kineta, acquiring 1.56 percent of the latter’s Kineta's shares wort
MSD released positive results from a phase 3 study of molnupiravir, an investigational pill to treat Covid-19, drawing attention from the pharmaceutical market.On Tuesday, Kyobo Securities published a monthly report to explain the meaning of the launch of Covid-19 oral treatments.Kim Jeong-hyeon, a